|Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population|
F Efficace, M Baccarani, M Breccia, G Alimena, G Rosti, F Cottone, ...
Blood, The Journal of the American Society of Hematology 118 (17), 4554-4560, 2011
|Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib|
F Efficace, M Baccarani, M Breccia, F Cottone, G Alimena, GL Deliliers, ...
Leukemia 27 (7), 1511-1519, 2013
|Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study|
F Efficace, M Baccarani, G Rosti, F Cottone, F Castagnetti, M Breccia, ...
British journal of cancer 107 (6), 904-909, 2012
|Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of …|
F Efficace, F Mandelli, G Avvisati, F Cottone, F Ferrara, E Di Bona, ...
J Clin Oncol 32 (30), 3406-3412, 2014
|Patient-versus physician-reporting of symptoms and health status in chronic myeloid leukemia|
F Efficace, G Rosti, N Aaronson, F Cottone, E Angelucci, S Molica, ...
Haematologica 99 (4), 788-793, 2014
|Leaving home, family support and intergenerational ties in Italy: Some regional differences|
E Santarelli, F Cottone
Demographic Research 21, 1-22, 2009
|Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study|
F Efficace, G Gaidano, M Breccia, MT Voso, F Cottone, E Angelucci, ...
The Lancet Oncology 16 (15), 1506-1514, 2015
|Profiling chronic myeloid leukemia patients reporting intentional and unintentional non-adherence to lifelong therapy with tyrosine kinase inhibitors|
F Efficace, G Rosti, F Cottone, M Breccia, F Castagnetti, A Iurlo, F Mandelli, ...
Leukemia research 38 (3), 294-298, 2014
|Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes|
F Efficace, G Gaidano, M Breccia, M Criscuolo, F Cottone, G Caocci, ...
British journal of haematology 168 (3), 361-370, 2015
|Tyrosine-kinase inhibitors and patient-reported outcomes in chronic myeloid leukemia: a systematic review|
F Efficace, A Cardoni, F Cottone, M Vignetti, F Mandelli
Leukemia Research 37 (2), 206-213, 2013
|Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes|
F Efficace, G Gaidano, M Sprangers, F Cottone, M Breccia, MT Voso, ...
Annals of oncology 25 (2), 447-454, 2014
|Health‐related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease|
F Efficace, F Mandelli, P Fazi, C Santoro, G Gaidano, F Cottone, ...
American journal of hematology 91 (10), 995-1001, 2016
|The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia|
F Efficace, G Rosti, M Breccia, F Cottone, JM Giesinger, F Stagno, A Iurlo, ...
Annals of hematology 95 (2), 211-219, 2016
|Psychological well-being and social support in chronic myeloid leukemia patients receiving lifelong targeted therapies|
F Efficace, M Breccia, F Cottone, I Okumura, M Doro, F Riccardi, G Rosti, ...
Supportive Care in Cancer 24 (12), 4887-4894, 2016
|Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes|
G Caocci, MT Voso, E Angelucci, R Stauder, F Cottone, G Abel, K Nguyen, ...
Leukemia research 39 (8), 859-865, 2015
|Patient‐reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes|
F Efficace, F Cottone, G Abel, P Niscola, G Gaidano, F Bonnetain, A Anota, ...
Cancer 124 (6), 1251-1259, 2018
|Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy|
F Efficace, V Santini, G La Nasa, F Cottone, C Finelli, L Borin, ...
BMJ supportive & palliative care 6 (1), 80-88, 2016
|The added value of propensity score matching when using health‐related quality of life reference data|
F Cottone, F Efficace, G Apolone, GS Collins
Statistics in medicine 32 (29), 5119-5132, 2013
|Development and feasibility of a patient-reported symptom checklist for chronic myeloid leukemia patients|
F Efficace, M Breccia, M Baccarani, G Alimena, G Lambertenghi Deliliers, ...
Haematologica 95 (S2), 189, 2010
|Health‐related quality of life in patients with chronic myeloid leukemia receiving first‐line therapy with nilotinib|
F Efficace, F Castagnetti, B Martino, M Breccia, M D'Adda, E Angelucci, ...
Cancer 124 (10), 2228-2237, 2018